2024-03-29T00:53:03Z
https://u-ryukyu.repo.nii.ac.jp/oai
oai:u-ryukyu.repo.nii.ac.jp:02015733
2022-10-31T07:43:29Z
1642838163960:1642838198944:1642838233003:1642838239325
1642838403551:1642838412624
[原著]第2, 3世代セフユム系抗生剤とオフロキサシンの抗菌作用について
Comparative study on antibacterial activity of ofloxacin, cefotiam and latamoxef against isolates from clinical specimens in Okinawa
仲宗根, 昇
比嘉, 直美
岩永, 正明
仲宗根, 勇
平良, 真幸
外間, 政哲
Nakasone, Noboru
Higa, Naomi
Iwanaga, Masaaki
Nakasone, Isamu
Taira, Shinko
Hokama, Seitetsu
MIC
OFLX
CTM
LMOX
Antibacterial activity of of loxacin as compared with that of cefotiam and latamoxef was determined on 500 isolates from clinical specimens. No bacterial species revealed higher sensitivity to CTM and LMOX than OFLX. In 5 species out of 7 (Staphylococcus aureus, streptococcus faecalis, Escherichia coli, Enterobacter spp., and Pseudomonus, aeruginosa), OFLX was definitely superior to the other 2 cephem drugs. In Serratia marcescens, OFLX and LMOX showed almost the same activity, and CTM was far inferior. In Klebsiella species, all 3 drugs revealed almost the same antimicrobial activity. The most potent bactericidal activity was seen in OFLX. Morphological alteration characterized by elongation of bacteria was observed after the treatment with each drug.
論文
http://purl.org/coar/resource_type/c_6501
琉球大学医学部
Faculty of Medicine, University of the Ryukyus
1986
VoR
0289-1530
AN10027430
琉球大学医学会雑誌 : 医学部紀要 = Ryukyu medical journal
3-4
9
178
168
jpn
open access
琉球医学会